Next-generation sequencing has diagnostic utility in challenging small/flat urothelial lesions
Authors:
Open Access
- 19 August 2024
- journal article
- research article
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 73, 152370
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Urothelial carcinoma in situ with “overriding” features can evade detection by mimicking umbrella cellsHuman Pathology, 2023
- Targeted Next-Generation Sequencing of Flat Urothelial Lesions Reveals Putative Pathobiological Pathways, Potential Biomarkers, and Rational Therapeutic TargetsLaboratory Investigation, 2023
- Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancerScientific Reports, 2022
- A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancerScientific Reports, 2021
- Urothelial carcinoma in situ: diagnostic updatePathology, 2021
- Macroscopic somatic clonal expansion in morphologically normal human urotheliumScience, 2020
- Extensive heterogeneity in somatic mutation and selection in the human bladderScience, 2020
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder CancerCell, 2017
- Best Practices Recommendations in the Application of Immunohistochemistry in the Bladder LesionsAmerican Journal of Surgical Pathology, 2014
- Comprehensive molecular characterization of urothelial bladder carcinomaNature, 2014